New York, New York (PRWEB) March 21, 2013
Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective medical devices, is keeping the public up-to-date about recent news concerning metal-on-metal hip implants such as the DePuy ASR. According to a March 20, 2013 report in MedPage Today, one facility is continuing to see high rates of revision more than two years after the ASR was recalled. In 2010, Johnson & Johnson’s DePuy unit recalled 93,000 hip implants citing a revision rate of 13 percent in five years.
“This information further demonstrates that a number of patients are still suffering from the alleged defects of the DePuy ASR,” said Daniel C. Burke, Senior Litigation Counsel at Parker Waichman LLP. “The facility stopped implanting this all-metal device a year and a half before it was recalled, and doctors are continuing to see a high rate of revision.” Mr. Burke says that the alleged flaws of the DePuy ASR are a prime example of why metal-on-metal hip implants are dangerous as a class of medical devices. Parker Waichman LLP has continued to offer free legal advice to patients implanted with such devices, and advises patients to speak with their doctors if they experience any symptoms of complications, such as:
- Early failure, revision surgery
- Metallosis, high levels of metal ions
- Difficulty walking, or a change in your ability to walk
MedPage Today reports that, at the annual meeting of the American Academy of Orthopaedic Surgeons, Chris J. Dangles, MD, of the Carle Foundation Hospital in Champaign, Illinois reported that the center was continuing to see high rates of revision surgery among patients implanted with the DePuy ASR. Between 2006 and 2009, 19 percent of ASR hips were revised. At four years, the failure rate was 24 percent, Dr. Dangles said. He reported that nearly half of the women implanted with the metal-on-metal hip implant underwent revision surgery.
When the ASR was globally recalled, Dangles and his colleagues’ contacted patients implanted with the all-metal devices to conduct metal ion testing, physical examinations and imaging studies to detect signs of complications such as metal poisoning or tissue damage.
Dr. Dangles pointed out that “Stability, increased range of motion, and decreased wear were the selling points” of the DePuy ASR, but five unusual revisions led the facility to stop using the implant 18 months before it was recalled by J&J. He said that the revisions included cases of adverse local tissue reaction, pseudotumors, fluid in the capsule, tissue staining and motion in the acetabular cup. Dangles concluded that "It was the right decision for us to stop using it even before the recall," and noted that "In addition, the device approval system failed all of us."
Litigation is currently underway over the DePuy ASR. Johnson & Johnson recently lost the first DePuy ASR case brought to trial. Jurors in Los Angeles ruled that the ASR was defective and awarded $8.3 million to Plaintiff, Loren Kransky, (Kransky v. DePuy, BC456086, California Superior Court, Los Angeles County (Los Angeles)). The second trial is currently underway in Chicago (Strum v. DePuy, 2011-L-9352, Circuit Court of Cook County, Law Division (Chicago)).
Parker Waichman LLP continues to offer free legal consultations to victims of DePuy ASR and other metal-on-metal hip implant injuries. If you or a loved one experienced premature failure of your implant or other health problems associated with a recalled DePuy ASR Hip Implant or other metal-on-metal hip implant, please contact their office by visiting the firm's DePuy ASR hip implant injury page at yourlawyer.com. Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).
Parker Waichman LLP
Gary Falkowitz, Managing Attorney